SinoMab BioScience's H1 Loss Narrows as Revenue Rises; Shares Fall 15%
SinoMab BioScience's H1 Loss Narrows as Revenue Rises; Shares Fall 15%
中侨生物科技营业收入增加，H1亏损收窄；股价下跌15%。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册